Josep Bonet

964 total citations
34 papers, 691 citations indexed

About

Josep Bonet is a scholar working on Nephrology, Cardiology and Cardiovascular Medicine and Molecular Biology. According to data from OpenAlex, Josep Bonet has authored 34 papers receiving a total of 691 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Nephrology, 7 papers in Cardiology and Cardiovascular Medicine and 6 papers in Molecular Biology. Recurrent topics in Josep Bonet's work include Chronic Kidney Disease and Diabetes (8 papers), Renal Diseases and Glomerulopathies (7 papers) and Renal Transplantation Outcomes and Treatments (4 papers). Josep Bonet is often cited by papers focused on Chronic Kidney Disease and Diabetes (8 papers), Renal Diseases and Glomerulopathies (7 papers) and Renal Transplantation Outcomes and Treatments (4 papers). Josep Bonet collaborates with scholars based in Spain and United States. Josep Bonet's co-authors include R. Romero, Assumpta Serra, Dolores López, Beatriu Bayés, Jordi Bonal, Noelia Pérez, Maruja Navarro-Díaz, Beatriz Bayés, Meritxell Ibernón and Ricardo Lauzurica and has published in prestigious journals such as PLoS ONE, Kidney International and Journal of the American Society of Nephrology.

In The Last Decade

Josep Bonet

33 papers receiving 670 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Josep Bonet Spain 16 303 178 124 121 117 34 691
Ran‐hui Cha South Korea 18 344 1.1× 149 0.8× 131 1.1× 154 1.3× 56 0.5× 52 912
Jocelyn S. Garland Canada 16 372 1.2× 117 0.7× 87 0.7× 117 1.0× 61 0.5× 30 812
Taner Baştürk Türkiye 15 397 1.3× 119 0.7× 90 0.7× 83 0.7× 59 0.5× 75 717
Miyeun Han South Korea 16 263 0.9× 146 0.8× 117 0.9× 69 0.6× 52 0.4× 73 720
Galip Güz Türkiye 17 197 0.7× 149 0.8× 188 1.5× 89 0.7× 69 0.6× 74 858
Julia Kerschbaum Austria 16 284 0.9× 92 0.5× 87 0.7× 72 0.6× 103 0.9× 35 679
Judith A. Benstein United States 13 278 0.9× 112 0.6× 163 1.3× 277 2.3× 154 1.3× 19 831
Nadia Stucchi Italy 10 473 1.6× 187 1.1× 84 0.7× 73 0.6× 185 1.6× 16 869
Luciana Bonfante Italy 19 347 1.1× 163 0.9× 169 1.4× 142 1.2× 74 0.6× 58 1.1k
Mariarosaria Campise Italy 13 243 0.8× 97 0.5× 54 0.4× 91 0.8× 53 0.5× 42 795

Countries citing papers authored by Josep Bonet

Since Specialization
Citations

This map shows the geographic impact of Josep Bonet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Josep Bonet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Josep Bonet more than expected).

Fields of papers citing papers by Josep Bonet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Josep Bonet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Josep Bonet. The network helps show where Josep Bonet may publish in the future.

Co-authorship network of co-authors of Josep Bonet

This figure shows the co-authorship network connecting the top 25 collaborators of Josep Bonet. A scholar is included among the top collaborators of Josep Bonet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Josep Bonet. Josep Bonet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Carreras‐Planella, Laura, David Cucchiari, Javier Juega, et al.. (2020). Urinary vitronectin identifies patients with high levels of fibrosis in kidney grafts. Journal of Nephrology. 34(3). 861–874. 22 indexed citations
2.
Bancu, Ioana, Laura Carreras‐Planella, Marta Tortajada, et al.. (2018). Molecular profile of urine extracellular vesicles from normo-functional kidneys reveal minimal differences between living and deceased donors. BMC Nephrology. 19(1). 189–189. 20 indexed citations
3.
Bonjoch, Anna, Núria Pérez‐Álvarez, Eugènia Negredo, et al.. (2017). Prevalence, evolution, and related risk factors of kidney disease among Spanish HIV-infected individuals. Medicine. 96(37). e7421–e7421. 15 indexed citations
4.
López, Dolores, et al.. (2017). Comparative differential proteomic analysis of minimal change disease and focal segmental glomerulosclerosis. BMC Nephrology. 18(1). 49–49. 25 indexed citations
5.
Poveda, Rafael, Juliana Draibe, Montserrat Díaz, et al.. (2017). Efficacy of mycophenolate treatment in adults with steroid-dependent/frequently relapsing idiopathic nephrotic syndrome. Clinical Kidney Journal. 10(5). 632–638. 6 indexed citations
6.
Bancu, Ioana, et al.. (2016). Low Insulin-Like Growth Factor-1 Level in Obesity Nephropathy: A New Risk Factor?. PLoS ONE. 11(5). e0154451–e0154451. 9 indexed citations
7.
Ariza, Aurelio, et al.. (2015). IgG4-related disease: description of a case with pulmonary lesions, mediastinal lymphadenopathies and rapidly progressive renal failure. Nefrología (English Edition). 35(2). 218–223. 5 indexed citations
8.
Bonjoch, Anna, Javier Juega, Jordi Puig, et al.. (2014). High Prevalence of Signs of Renal Damage Despite Normal Renal Function in a Cohort of HIV-Infected Patients: Evaluation of Associated Factors. AIDS Patient Care and STDs. 28(10). 524–529. 17 indexed citations
9.
Ibernón, Meritxell, Dolores López, M.C. Pastor, et al.. (2014). Urinary Peptide Profiling to Differentiate between Minimal Change Disease and Focal Segmental Glomerulosclerosis. PLoS ONE. 9(1). e87731–e87731. 20 indexed citations
10.
Lauzurica, Ricardo, et al.. (2013). Magnetic bead-based proteomic technology to study paricalcitol effect in kidney transplant recipients. European Journal of Pharmacology. 709(1-3). 72–79. 11 indexed citations
11.
Bonet, Josep, et al.. (2013). Metabolic syndrome in hemodialysis patients as a risk factor for new-onset diabetes mellitus after renal transplant: a prospective observational study. Diabetes Metabolic Syndrome and Obesity. 6. 339–339. 11 indexed citations
12.
Bonet, Josep, et al.. (2012). Avaluació de competències socials a l’ensenyament d’Enginyeria Química. 1(1). 1 indexed citations
13.
Ibernón, Meritxell, Josep Bonet, Beatriz Bayés, et al.. (2012). Uromodulin and α<sub>1</sub>-Antitrypsin Urinary Peptide Analysis to Differentiate Glomerular Kidney Diseases. Kidney & Blood Pressure Research. 35(5). 314–325. 22 indexed citations
14.
Lauzurica, Ricardo, Beatriz Bayés, José M. Hernández, et al.. (2008). Pretransplant inflammation: a risk factor for delayed graft function?. Journal of Nephrology. 21(2). 221–228. 21 indexed citations
15.
Romero, R., Josep Bonet, Alejandro de la Sierra, María Teresa Aguilera, & On Behalf Of The Cannulate Tavr Expanded Investigators. (2007). Undiagnosed obesity in hypertension: Clinical and therapeutic implications. Blood Pressure. 16(6). 347–353. 20 indexed citations
16.
Sierra, Alejandro de la, et al.. (2006). Prevalencia y características del síndrome metabólico en la población hipertensa española. Medicina Clínica. 126(11). 406–409. 28 indexed citations
17.
Bonet, Josep, et al.. (2004). ACE inhibitors improve nephrin expression in Zucker rats with glomerulosclerosis. Kidney International. 67(93). S10–S14. 42 indexed citations
18.
Bonet, Josep, et al.. (2003). Supervised versus Recommended Physical Exercise in Hypertensive Women. Is its Recommendation Enough?. Blood Pressure. 12(3). 139–144. 5 indexed citations
19.
Serra, Assumpta, R. Romero, Beatriz Bayés, Dolores López, & Josep Bonet. (2002). Is there a need for changes in renal biopsy criteria in proteinuria in type 2 diabetes?. Diabetes Research and Clinical Practice. 58(2). 149–153. 46 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ran‐hui Cha Breakdown of academic impact, for papers by Jocelyn S. Garland Breakdown of academic impact, for papers by Taner Baştürk Breakdown of academic impact, for papers by Miyeun Han Breakdown of academic impact, for papers by Galip Güz Breakdown of academic impact, for papers by Julia Kerschbaum Breakdown of academic impact, for papers by Judith A. Benstein Breakdown of academic impact, for papers by Nadia Stucchi Breakdown of academic impact, for papers by Luciana Bonfante Breakdown of academic impact, for papers by Mariarosaria Campise
Rankless by CCL
2026